BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Damania B, Münz C. Immunodeficiencies that predispose to pathologies by human oncogenic γ-herpesviruses. FEMS Microbiol Rev 2019;43:181-92. [PMID: 30649299 DOI: 10.1093/femsre/fuy044] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Messick TE, Tolvinski L, Zartler ER, Moberg A, Frostell Å, Smith GR, Reitz AB, Lieberman PM. Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANA. Molecules 2020;25:E1760. [PMID: 32290261 DOI: 10.3390/molecules25071760] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Biswas A, Zhou D, Fiches GN, Wu Z, Liu X, Ma Q, Zhao W, Zhu J, Santoso NG. Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination. PLoS Pathog 2021;17:e1009764. [PMID: 34297745 DOI: 10.1371/journal.ppat.1009764] [Reference Citation Analysis]
3 Münz C. The Role of Dendritic Cells in Immune Control and Vaccination against -Herpesviruses. Viruses 2019;11:E1125. [PMID: 31817510 DOI: 10.3390/v11121125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Münz C. Regulation of the Macroautophagic Machinery, Cellular Differentiation, and Immune Responses by Human Oncogenic γ-Herpesviruses. Viruses 2021;13:859. [PMID: 34066671 DOI: 10.3390/v13050859] [Reference Citation Analysis]
5 Deng Y, Chatterjee B, Zens K, Zdimerova H, Müller A, Schuhmachers P, Ligeon LA, Bongiovanni A, Capaul R, Zbinden A, Holler A, Stauss H, Hammerschmidt W, Münz C. CD27 is required for protective lytic EBV antigen-specific CD8+ T-cell expansion. Blood 2021;137:3225-36. [PMID: 33827115 DOI: 10.1182/blood.2020009482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Münz C. Latency and lytic replication in Epstein-Barr virus-associated oncogenesis. Nat Rev Microbiol 2019;17:691-700. [PMID: 31477887 DOI: 10.1038/s41579-019-0249-7] [Cited by in Crossref: 84] [Cited by in F6Publishing: 83] [Article Influence: 42.0] [Reference Citation Analysis]
7 Münz C. The Role of Lytic Infection for Lymphomagenesis of Human γ-Herpesviruses. Front Cell Infect Microbiol 2021;11:605258. [PMID: 33842383 DOI: 10.3389/fcimb.2021.605258] [Reference Citation Analysis]
8 Münz C. Cytotoxicity in Epstein Barr virus specific immune control. Curr Opin Virol 2021;46:1-8. [PMID: 32771660 DOI: 10.1016/j.coviro.2020.07.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Münz C. Redirecting T Cells against Epstein-Barr Virus Infection and Associated Oncogenesis. Cells 2020;9:E1400. [PMID: 32512847 DOI: 10.3390/cells9061400] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
10 Bauer M, Jasinski-Bergner S, Mandelboim O, Wickenhauser C, Seliger B. Epstein-Barr Virus-Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies. Cancers (Basel) 2021;13:5189. [PMID: 34680337 DOI: 10.3390/cancers13205189] [Reference Citation Analysis]
11 Zelazowska MA, Dong Q, Plummer JB, Zhong Y, Liu B, Krug LT, McBride KM. Gammaherpesvirus-infected germinal center cells express a distinct immunoglobulin repertoire. Life Sci Alliance 2020;3:e201900526. [PMID: 32029571 DOI: 10.26508/lsa.201900526] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Münz C. Probing Reconstituted Human Immune Systems in Mice With Oncogenic γ-Herpesvirus Infections. Front Immunol 2020;11:581419. [PMID: 33013936 DOI: 10.3389/fimmu.2020.581419] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Walter M, Verdin E. Viral gene drive in herpesviruses. Nat Commun 2020;11:4884. [PMID: 32985507 DOI: 10.1038/s41467-020-18678-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Münz C. Immune Escape by Non-coding RNAs of the Epstein Barr Virus. Front Microbiol 2021;12:657387. [PMID: 34234755 DOI: 10.3389/fmicb.2021.657387] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Münz C. Natural Killer Cell Responses during Human γ-Herpesvirus Infections. Vaccines (Basel) 2021;9:655. [PMID: 34203904 DOI: 10.3390/vaccines9060655] [Reference Citation Analysis]
16 Schuhmachers P, Münz C. Modification of EBV Associated Lymphomagenesis and Its Immune Control by Co-Infections and Genetics in Humanized Mice. Front Immunol 2021;12:640918. [PMID: 33833760 DOI: 10.3389/fimmu.2021.640918] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Münz C. Immune Control and Vaccination against the Epstein-Barr Virus in Humanized Mice. Vaccines (Basel) 2019;7:E217. [PMID: 31861045 DOI: 10.3390/vaccines7040217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Caduff N, McHugh D, Rieble L, Forconi CS, Ong'echa JM, Oluoch PO, Raykova A, Murer A, Böni M, Zuppiger L, Schulz TF, Blackbourn DJ, Chijioke O, Moormann AM, Münz C. KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection. Cell Rep 2021;35:109056. [PMID: 33951431 DOI: 10.1016/j.celrep.2021.109056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
19 Rühl J, Leung CS, Münz C. Vaccination against the Epstein-Barr virus. Cell Mol Life Sci 2020;77:4315-24. [PMID: 32367191 DOI: 10.1007/s00018-020-03538-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
20 Šudomová M, Berchová-Bímová K, Marzocco S, Liskova A, Kubatka P, Hassan STS. Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers. Viruses 2021;13:1014. [PMID: 34071559 DOI: 10.3390/v13061014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]